Perampanel Confirms to Be Effective and Well-Tolerated as an Add-On Treatment in Patients With Brain Tumor-Related Epilepsy (PERADET Study)

Background: Epilepsy is one of the most common symptoms of brain tumors. It is often drug resistant and generally worsen patients' quality of life (QoL). Brain tumors release glutamate among other mediators, contributing to seizures onset, and this is accompanied by an increased AMPA receptors&...

Descripción completa

Detalles Bibliográficos
Autores principales: Coppola, Antonietta, Zarabla, Alessia, Maialetti, Andrea, Villani, Veronica, Koudriavtseva, Tatiana, Russo, Emilio, Nozzolillo, Agostino, Sueri, Chiara, Belcastro, Vincenzo, Balestrini, Simona, Ferlazzo, Edoardo, Giannarelli, Diana, Bilo, Leonilda, Maschio, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336340/
https://www.ncbi.nlm.nih.gov/pubmed/32695064
http://dx.doi.org/10.3389/fneur.2020.00592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336340/
https://www.ncbi.nlm.nih.gov/pubmed/32695064
http://dx.doi.org/10.3389/fneur.2020.00592

Ejemplares similares